help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmid-Kotsas, A.
Right arrow Articles by Bachem, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmid-Kotsas, A.
Right arrow Articles by Bachem, M. G.
(American Journal of Pathology. 1999;155:1749-1758.)
© 1999 American Society for Investigative Pathology


Regular Articles

Lipopolysaccharide-Activated Macrophages Stimulate the Synthesis of Collagen Type I and C-Fibronectin in Cultured Pancreatic Stellate Cells

Alexandra Schmid-Kotsas*, Hans-Jürgen Gross*, Andre Menke{dagger}, Hans Weidenbach{dagger}, Guido Adler{dagger}, Marco Siech{ddagger}, Hans Beger{ddagger}, Adolf Grünert* and Max G. Bachem*

From the Departments of Clinical Chemistry and Pathobiochemistry,*
Internal Medicine I,{dagger}
and General Surgery,{ddagger}
University Hospital, Ulm, Germany


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We have recently identified and characterized pancreatic stellate cells (PSC) in rats and humans (Gastroenterology 1998, 15:421–435). PSC are suggested to represent the main cellular source of extracellular matrix in chronic pancreatitis. Now we describe a paracrine stimulatory loop between human macrophages and PSC (rat and human) that results in an increased extracellular matrix synthesis. Native and transiently acidified supernatants of cultured macrophages were added to cultured PSC in the presence of 0.1% fetal calf serum. Native supernatants of lipopolysaccharide-activated macrophages stimulated the synthesis of collagen type I 1.38 ± 0.09-fold of control and c-fibronectin 1.89 ± 0.18-fold of control. Transiently acidified supernatants stimulated collagen type I and c-fibronectin 2.10 ± 0.2-fold and 2.80 ± 0.05-fold of control, respectively. Northern blot demonstrated an increased expression of the collagen-I-({alpha}-1)-mRNA and fibronectin-mRNA in PSC 10 hours after addition of the acidified macrophage supernatants. Cell proliferation measured by bromodeoxyuridine incorporation was not influenced by the macrophage supernatants. Unstimulated macrophages released 1.97 pg TGFß1/µg of DNA over 24 hours and lipopolysaccharide-activated macrophages released 6.61pg TGFß1/µg of DNA over 24 hours. These data together with the results that, in particular, transiently acidified macrophage supernatants increased matrix synthesis, identify TGFß as the responsible mediator. In conclusion, our data demonstrate a paracrine stimulation of matrix synthesis of pancreatic stellate cells via TGFß1 released by activated macrophages. We suggest that macrophages might play a pivotal role in the development of pancreas fibrosis.



    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Chronic pancreatitis is characterized by the presence of chronic inflammatory lesions, the destruction of exocrine parenchyma, and fibrosis.1 Until now the pathobiochemical and molecular mechanisms resulting in pancreas fibrosis have been controversial and largely unknown. Fibroblast and fibroblast-like cell activation was reported to be a common observation in acute and chronic pancreatitis.2-6 It has been suggested that periacinar fibroblast-like cells might play a role in fibrogenesis by synthesizing significant amounts of extracellular matrix (ECM), in particular collagens.7,8 Studies from our group have shown that in the cerulein-induced pancreatitis model, proliferation of acinar and centroacinar cells is associated with an increase in mitotic activity of fibroblasts, which is followed by a stimulated synthesis and deposition of collagen.5,9 In an earlier study, we illustrated an enhanced expression of transforming growth factor ß (TGFß) during regeneration from cerulein-induced pancreatitis in acinar cells and stromal cells of the rat pancreas, which was followed by stimulated matrix synthesis.10 Furthermore, we identified and characterized the matrix-producing cell type responsible for pancreas fibrosis, the pancreatic stellate cell (PSC) in mice, rats and humans.11,12 Phenotypic transformation of PSCs is characterized by a disappearance of fat droplets and retinyl-esters, development of a prominent endoplasmic reticulum, enhanced expression of smooth muscle {alpha}-actin, and increased synthesis of collagen types I and III and fibronectin.11

Pancreas fibrosis is commonly associated with chronic inflammation.4 In chronic pancreatitis and in pancreas carcinoma, infiltrating mononuclear cells13 might potentiate fibrogenesis by the release of cytokines stimulating stromal cells14 and by their cytotoxic effects.15 The decreased intestinal motility during pancreatitis causes a bacterial translocation to the peritoneal fluid, lymph, blood, liver, and pancreas.16 Bacterial lipopolysaccharides (LPS) and the LPS-binding protein form a complex that binds to the surface receptor CD14 of the invaded monocytes, triggering the cells to become activated.17,18 LPS activation of monocytes/macrophages and aggregating platelets in areas of inflammation release several polypeptide growth factors including TGFß, TGF{alpha}/EGF, basic fibroblast growth factor (bFGF), and platelet-derived growth factor (PDGF).19-22 It is suggested that these factors are responsible for stimulating ECM synthesis and proliferation of PSC.

Because macrophages are located close to PSC,11 their capacity to release TGFß is of particular interest. Recent investigations revealed that TGFß is a multifunctional regulator of cell growth and differentiation.23 TGFß stimulates the synthesis of ECM components and inhibits matrix degradation.24 TGFß is secreted as a latent form associated with a latency-associated peptid. Latent TGFß-binding protein (LTBP) is covalently bound to the latency-associated peptid and forms a high-molecular-weight complex termed latent TGFß complex.25 LTBP is assumed to play a strategic role in the assembly, secretion, and activation of latent TGFß.26 In chronic pancreatitis, the TGFß precursor was detected mainly in mononuclear cells located in fibrotic areas.27 LTBP is also predominantly present in mononuclear cells and in the ECM around them. The presence of both pro-TGFß and LTBP in monocytes and/or macrophages in areas of fibrosis strongly suggests that this cytokine is involved in the pathophysiology of chronic pancreatitis.27

In the present study, we demonstrate that transiently acidified supernatants of LPS stimulated human monocyte-derived macrophages contain TGFß and stimulated the synthesis of fibronectin and collagen type I in cultured PSCs. These findings suggest that activated macrophages play a critical role in pancreas fibrogenesis by stimulating matrix synthesis of PSCs in a paracrine way.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Reagents

Materials were purchased from the following sources: Ficoll-Paque from Pharmacia, Biotech (Uppsala, Sweden); biotin labeled CD14(My4) and CD3-ECD from Coulter Immunotech (Hamburg, Germany); rabbit anti-human collagen type I and biotin-labeled goat anti-human collagen type III from Chemicon (Temecula, CA); rabbit anti-fibronectin from Behring Diagnostics (Marburg, Germany); biotin labeled anti-rabbit, biotin labeled anti-mouse, HRP anti-rabbit, biotin labeled anti-goat, HRP anti-mouse, fluorescein-conjugated streptavidin, HRP-conjugated streptavidin, mouse anti-BrdU, anti-CD19-PECy5, and anti-CD14-PE from DAKO (Hamburg, Germany); streptavidin-Red 613 from Gibco BRL (Eggenstein, Germany); mouse anti-{alpha}-smooth-muscle actin, bromodeoxyuridine, and the High Pure RNA Extraction Kit from Boehringer Mannheim (Mannheim, Germany); TSA Indirect from NEN Life Science Products (Boston, MA); fluorescein-conjugated Escherichia coli and propidium jodide (Orpegen, Heidelberg, Germany); trypan blue, bisbenzimide, calf thymus DNA, yeast t-RNA, diethylendtriaminepentaacetic (DTPA), monoclonal anti-fibronectin, and ß-aminopropionitrile from Sigma (Deisenhofen, Germany); ascorbic acid from Merck (Darmstadt, Germany); enhancement solution and europium-conjugated streptavidin from Wallac Oy (Turku, Finland); and TGFß1-sR-II/Fc chimera and biotinylated anti-human TGFß1 from R&D Systems (Minneapolis, MN). The 18S rRNA probe was generously provided by Dr. T. M. Gress (University Ulm, Germany). Ninety-six-well microtiter plates (Maxi Sorp) were from Nunc GmbH (Wiesbaden, Germany), cell culture plates and flasks were from Falcon (Becton Dickinson, Heidelberg, Germany) and petriPerm was from In Vitro Systems + Services (Osterode, Germany). Hybond-N membranes were purchased from Amersham-Buchler (Braunschweig, Germany).

Monocyte Isolation and Culture

Peripheral blood mononuclear cells were isolated from buffy coats of different donors by Ficoll-Paque gradient centrifugation. The mononuclear fraction was washed in PBS and then resuspended in RPMI 1640 containing 1% L-glutamine, 100 IU/ml penicillin, 100 µg/ml streptomycin and 10% fetal calf serum (FCS). Aliquots of the cell suspension (5 x 106 mononuclear cells/ml) were allowed to adhere in 75 cm2 tissue culture flasks in 37°C in a humidified 5% CO2 environment. For immunofluorescence staining cells were seeded on glass coverslips (1 cm2) in 6-well plates. To harvest cells for flow cytometric analysis, cells were seeded on petriPerm. After 2 hours the nonadherent cells were removed and fresh medium was added. Medium was changed each third day and cells were cultured for up to 14 days.

Production of Conditioned Media

Cultured macrophages in 75-cm2 flasks (10–14 days after seeding) were washed with RPMI 1640. Thereafter 10 ml fresh RPMI per flask (with antibiotics, without FCS) was added and conditioned for 24 hours in the absence and presence of 8 µg/ml LPS. Conditioned media were removed under sterile conditions, centrifuged (800 rpm, 5 minutes, 4°C) to remove cell debris, and stored at -80°C. The media were dialyzed for 36 hours against 100 vol distilled water at 4°C in tubings (ZelluTrans, Roth, Karlsruhe, Germany) with 3.5-kd molecular cutoff. Thereafter media were concentrated 10-fold by lyophilization and sterilized by passing through a 0.22-µm pore size filter (Millex-GS, Millipore). To activate latent TGFß1, aliquots of the media were acidified with 1 mol/L HCl for 10 minutes, then neutralized by adding 1.2 N NaOH/0.5 mol/L Hepes.

Pancreatic Stellate Cell Isolation and Culture

Human pancreatic stellate cells were isolated by outgrowth, using explant techniques from histologically fibrotic areas of the pancreas surgically resected from patients with chronic pancreatitis. Small tissue blocks were cut (0.5–1 mm3) and seeded in 10-cm2 uncoated culture wells (6 per plate, 3–5 pieces/well) in the presence of 10 to 20% FCS in a 1:1 (v:v) mixture of Dulbecco’s modified Eagle’s medium (DMEM) with Ham’s F12 medium. L-glutamine (2 mmol/L), penicillin/streptomycin, and amphotericine were freshly added. Tissue blocks were cultured at 37°C in a 5% CO2-air humidified atmosphere. Eighteen hours after seeding, culture medium was changed and 24 hours later the small tissue blocks were transferred to new culture plates. The pancreatic stellate cells grew out in high number and purity from the tissue blocks 1 to 3 days later. The small tissue blocks were removed after 2 to 3 weeks.

To obtain a higher number of cells with the inactivated resting fat storing phenotype, the cells were isolated by density gradient centrifugation from the pancreas of untreated male Wistar rats as described.11 Briefly, after the animals were anesthetized with pentobarbital, the abdomen was opened, the common bile duct was ligated, and a cannula was inserted into the biliopancreatic duct. The rats were exsanguinated and collagenase-containing Eagle’s medium (1 mg/5 ml) was instilled intraductally. The distended pancreas was removed and shaken in an Erlenmeyer flask (37°C, 15 minutes.). After this first digestion the pancreas was minced, followed by a second digestion with collagenase (1.75 mg/5 ml, 45 minutes.). Dispersion was accomplished by up-and-down suction through cannulas with decreasing diameters. After dissociation the acini and cells were filtered through a 250-µm nylon cloth and centrifuged after layering the filtrate on top of a dextran-Eagle-HEPES density gradient. Once centrifuged, cells were collected from the top of the gradient, washed twice, resuspended in Tris-buffered saline, and transferred on top of a Iodixanol (OptiPrep) density gradient. After another centrifugation, cells were collected from the top of the gradient, washed, and suspended in DMEM with 10% FCS, antibiotics, amphotericine, and L-glutamine. Thereafter cells were seeded in a density of 4 x 104 cells/cm2.

Cells were cultured at 37°C in a 5% CO2 humidified atmosphere. The medium consisted of DMEM/Ham’s F12 (1:1, v:v) with 10% FCS, 2% L-glutamine, 100 IU/ml penicillin, 100 µg/ml streptomycin, and 1% amphotericine. Medium was changed 3 times a week. After reaching confluency, cells were subcultured by trypsinization using a 0.025% trypsin solution containing 0.01% EDTA in phospate-buffered saline. Once the cell numbers were counted, they were again suspended in a complete medium and seeded with a density of 3–5 x 104 cells/cm2. To increase the cell number to obtain sufficient amounts of RNA, cells were seeded in 75-cm2 culture flasks (25 ml medium/flask).

Stimulation of Pancreatic Stellate Cells with Media Conditioned by Macrophages

Experiments were performed using PSC between passage 3–8. After passage PSC were cultured for 2 to 3 days in DMEM/HAM’s F12 (1/1, v/v) in the presence of 10% FCS. Twelve hours before addition of macrophage supernatants, medium was changed to DMEM/HAM’s F12 with 0.1% FCS. To study cell proliferation and matrix synthesis PSC were cultured in 24-well plates (2 cm2/well, 1 ml medium). To study matrix synthesis, native and transiently acidified macrophage supernatants (40 and 160 µl/ml) were added and cultures were stopped 24 hours later. To study cell proliferation BrdU (final concentration 0.5 x 10-5 M) was added 6 hours after addition of 40 µl/ml native and transiently acidified macrophage supernatants. Cultures were stopped 18 hours later. To perform immunofluorescence microscopy of collagen and fibronectin, PSC were seeded on 1-cm2 glass coverslips in 6-well plates and incubated with 40 µl/ml transiently acidified macrophage supernatant. Cultures were stopped 38 hours later. To isolate mRNA, PSCs were grown in 75 cm2 flasks containing 10 ml medium. To subconfluent quiescent cells (cultured for 12 hours in the presence of 0.1% FCS) 40µl/ml transiently acidified macrophage supernatant was added and cultures were stopped 10 hours later.

In all experiments the baseline (negative) control represents PSC cultured in DMEM/HAM’s F12 with 0.1% FCS.

Immunfluorescence Microscopy and Flow Cytometric Analysis

Glass coverslips with cultured hPSC were washed in PBS to remove medium proteins, fixed for 30 minutes in -20°C acetone, and blocked with TNB for 45 minutes. For collagen type I the staining sequence was primary antibody (rabbit-anti-human-collagen I, 1:100), second antibody (HRP-anti-rabbit, 1:100), biotin-TSA-reagent (1:40) and streptavidin-FITC (1:100). For collagen type III the staining sequence was primary antibody (biotin labeled goat-anti-human-collagen III, 1:100), HRP-streptavidin (1:100), biotin-TSA-reagent (1:40) and streptavidin-FITC (1:100). The staining sequence for fibronectin was primary antibody (rabbit-anti-fibronectin, 1:100), second antibody (biotin-anti-rabbit, 1:100) and streptavidin-FITC (1:100). For {alpha}-smooth muscle actin the staining sequence was primary antibody (mouse anti-{alpha}-smooth muscle actin, 1:50), second antibody (HRP-anti-mouse, 1:50), biotin-TSA-reagent (1:40) and streptavidin-FITC (1:100). Cells were viewed by epifluorescence microscopy (Carl Zeiss, Oberkochen, Germany) with appropriate filter sets.

To demonstrate phagocytosis macrophages were incubated with 3 x 107 opsonized FITC-conjugated E. coli for 6 hours at 37°C, washed with PBS, incubated first with biotin-anti-CD14 (1:33) and then with streptavidin-Red 613 (1:100). Thereafter, cells were fixed for 30 minutes in 4% formaldehyde. DNA was counterstained with bisbenzimide. Viability of cultured macrophages was assessed by trypan blue exclusion.

To analyze the cells by flow cytometry, macrophages were grown in petriPerm for 10 to 14 days and harvested by scraping. Thereafter cells were washed with PBS, resuspended, and analyzed for expression of CD14, CD3, and CD19 using an EPICS XL flow cytometer (Coulter Immunotech, Hamburg, Germany). Viable cells were detected by propidium jodide exclusion.

Quantitative Determination of Extracellular Matrix Synthesis

To measure collagen type I cells were cultured in DMEM/HAM’s F12 with 0.1% FCS in the presence of ascorbic acid (100 µg/ml) and ß-aminopropionitrile (100 µg/ml). By time-resolved fluorescence-immunoassay collagen type I was measured in culture supernatants 24 hours after stimulation. Briefly, 100 µl cell culture supernatant (diluted 1:4 with 0.05 mol/L NaHCO3, pH 9.1) were transferred to 96-well microtiter plates (Nunc-Maxi Sorp) and incubated overnight at 4°C. After 3 washing steps (wash buffer: Tris 0.05 mol/l, NaCl 0.15 mol/l, Tween 20 0.05%, pH 7.5) plates were blocked during 2 hours with assay buffer (Tris 0.05 mol/l, NaCl 0.15 mol/l, dry milk powder 5%, pH 7.5). Thereafter, the plates were incubated for 3 hours with a polyclonal rabbit-anti-human-collagen type I (diluted 1:500 in assay buffer). After washing 3 times the plates were incubated for 2 hours with the second antibody (biotin-labeled anti-rabbit IgG diluted 1:1000 in assay buffer). Thereafter, an Europium-labeled streptavidin (diluted 1:1000 in assay buffer) was added and incubated for 1 hour. After additional 3 washing steps, 100 µl enhancement solution was added for 30 minutes at room temperature and thereafter time-resolved fluorescence of the Europium chelate was measured using a Victor 1420 Multilabel Counter (Fa. Wallac, Turku, Finland). All measurements were done in duplicate.

To measure c-fibronectin, time-resolved fluorescence immunoassay was used. Briefly, 96-well microtiter plates were coated 3 hours at room temperature with gelatin (10 µg/ml) in coating buffer (0.05 mol/L NaHCO3, pH 9.1) and thereafter blocked overnight at 4°C using assay buffer (Tris 0.05 mol/L, NaCl 0.15 mol/L, RIA grade albumin 0.5%, pH 7.7). Standards (100 µl, 5000–19 ng/ml) and culture supernatants diluted in assay buffer were added and incubated overnight at room temperature. Thereafter, the plates were incubated for 1 hour with a monoclonal mouse-anti-c-fibronectin diluted 1:1000 in assay buffer. After washing 3 times the plates were incubated for 1 hour with the second antibody (biotin-labeled anti-mouse IgG diluted 1:1000 in assay buffer) followed by 3 washing steps. Thereafter, an Europium-labeled strepavidin (diluted 1:1000 in assay buffer) was added and incubated for 1 hour. After 3 more washing steps, 100 µl enhancement solution was added for 30 minutes at room temperature and thereafter time-resolved fluorescence of the Europium chelate was measured using a Victor 1420 Multilabel Counter. All measurements were done in duplicate.

Quantitative Determination of TGFß

TGFß1 was measured by time-resolved fluorescence immunoassay. Ninety-six-well microtiter plates were coated overnight at room temperature with TGFß1-sR-II/Fc Chimera (0.2 µg/ml) diluted in coating buffer (0.05 mol/L NaHCO3, pH 9.2). After 3 washing steps (wash buffer: PBS, Tween 20 0.05%, pH 7.4), plates were blocked during 2 hours at room temperature with blocking buffer (PBS, Tween 20 5%, sucrose 5%, NaN3 0.05%) and again washed 3 times. One-hundred-microliter standards (5 ng/ml - 156 pg/ml) diluted in DMEM with 0.1% RIA grade albumin and culture supernatants diluted in diluent (PBS, milk powder 0.5%, Tween 20 0.05%) were added and incubated for 2 hours at room temperature. After 3 washing steps, plates were incubated with biotin anti-human TGBß1 diluted 1:250 in diluent (20 mmol/L Trizma-base, 150 mmol/L NaCl, 0.1% RIA grade albumin) for 2 hours, followed by 3 washing steps. Thereafter, an Europium-labeled streptavidin (diluted 1:1000 in diluent) was added and incubated for 1 hour. After additional 5 washing steps, 100 µl of enhancement solution were added for 30 minutes at room temperature and thereafter time-resolved fluorescence of the Europium chelate was measured using a Victor 1420 Multilabel Counter. All measurements were done in duplicate.

Measurement of DNA

DNA was quantified as previously described28 by fluorometry using bisbenzimide and calf thymus DNA as a standard. Fluorescence (Ex. 350 nm, Em. 450 nm) was measured with a Victor 1420 Multilabel Counter.

Measurement of Cell Proliferation

Bromodeoxyuridine (BrdU) incorporation was quantified by time-resolved fluorescence of a Europium chelate.29 Briefly, cells were labeled for 18 hours with BrdU (5 x 10-5 M). Thereafter, cell cultures were washed twice with TNT (0.1 Mol/L Tris-HCl, 0.15 Mol/L NaCl, 0.5% RIA grade albumin, pH 7.4), fixed using ethanol/acetic acid (95/5, v/v), and then incubated for 20 minutes at 4°C with 0.05 mol/L HCl. After another washing step, DNA was cleaved by incubation for 45 minutes at 80°C with formamide/trisodium citrate (88 mg trisodium citrate in 38 ml formamide). After 2 washing steps, nonspecific binding was blocked by incubation with FCS (diluted 1:1 with TNB: 0.1 mol/L Tris-HCl, 0.15 mol/L NaCl, 0.05% Tween 20, pH 7.4) followed by 3 washing steps. Thereafter, first antibody (mouse anti-BrdU IgG diluted 1:500 in TNB) was added and incubated with gentle shaking for 2 hours at 22°C. After 3 more washing steps, a second antibody (biotin-labeled anti-mouse IgG, diluted 1:500 in TNB) was added and incubated for another 60 minutes; thereafter DTPA (diethylentriaminepantaacetic acid, 20 µmol in TNB, pH 7.4) was added and incubated for 15 minutes at room temperature. After 3 additional washing steps, Europium-labeled streptavidin (diluted in TNB 1:1000) was added and incubated for 1 hour. After 5 washing steps, enhancement solution (150 µl/well) was added and incubated for 45 minutes at 22°C. Finally, time-resolved fluorescence of the europium-chelate was counted in a 100-µl aliquot using a Delfia Victor 1420 Multilabel Counter (Wallac).

RNA Isolation and Northern Blot

PSC cultures were stopped 10 hours after stimulation with macrophage supernatants to extract total RNA using the High Pure RNA Isolation Kit. For Northern blot analysis, 30 µg of total RNA was separated by gel electrophoresis in 1% agarose and 2.2 mol/L formaldehyde and transferred by capillary elution to Hybond-N membranes. Ethidium bromide staining of the agarose gels and hybridization with an 18S ribosomal RNA probe were used to verify equal loading and blotting of total RNA. Purified cDNA probes were labeled with [32P]dCTP. Prehybridizations (4–6 hours) and hybridizations (14 hours) were carried out in 6x standard saline citrate (1x SSC = 150 mmol/L NaCl, 15 mmol/L sodium citrate), 5x Denhardt’s reagent, 0.5% sodium dodecyl sulfate (SDS), 100 µg/ml yeast t-RNA, 50 µg/ml sonicated human placenta DNA, 10 µg/ml polyU-homopolymer, and 50% formamide at 42°C. The hybridization buffer was supplemented with 0.5 x 106 cpm/ml labeled cDNA. The membranes were washed several times with decreasing concentrations of SSC + 0.1% SDS, the final high stringency wash was done in 0.2x SSC. Exposure to X-ray films was done at -70°C for 7 to 10 days.

Statistics

Quantitative measurements of c-fibronectin, collagen type I, DNA, BrdU incorporation, and TGFß1 were done in duplicate. Results for fibronectin, DNA, and BrdU incorporation are presented as mean ± SD of at least three independent experiments. To measure collagen type I and TGFß1, two independent experiments were performed. Each condition in the different experiments was tested using three or six cultures (three or six wells). Analysis of variance was used to compare different data groups.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mononuclear Cell Isolation, Culture, and Macrophage Characterization

Mononuclear cells were isolated from buffy coats, washed, counted, resuspended in complete medium (5 x 106 cells/ml), and seeded in culture flasks, glass coverslips, and petriPerm with a density of 6.6 x 104 cells/cm2. After 2 hours the nonadherent cells were removed during a medium change. During the next 2 weeks in culture monocytes differentiated to macrophages, showing characteristic variations in morphology ranging from spindle-shaped cells to large spread cells with many lamellipods (Figure 1A) . Immunofluorescence staining (Figure 1B) demonstrated that >95% of the monocyte-derived macrophages expressed CD14 after 14 days in culture (Figure 1B) . Furthermore, during an incubation period of 6 hours, 50 to 70% of the cells showed phagocytic activity toward fluorescein-labeled E. coli (Figure 1B) . Viability of cells which had been cultured for 2 weeks was above 95%. Flow cytometric analysis of cells cultured for 10 to 14 days in petriPerm showed about 75% CD14-positive cells (2/3 weakly and 1/3 strongly positivity), 19% CD3-positive cells, and 2% CD19-positive cells.



View larger version (116K):
[in this window]
[in a new window]
 
Figure 1. A: Phase contrast image of cultured macrophages. Peripheral blood mononuclear cells were isolated from buffy coats by gradient centrifugation. Cells were seeded on glass coverslips, and after 2 hours the nonadherent cells were removed by washing. Medium was changed each third day. Phase contrast micrography was performed with living cells that had been cultured for 10 days (original magnification, x400). B: Fluorescence micrograph of cultured macrophages. CD14 immunostaining and FITC-E. coli phagocytosis of macrophages derived from peripheral blood mononuclear cells during culture for 2 weeks. Bevor fixation cells were incubated with FITC-labeled E. coli for 6 hours (original magnification, x400).

 
Culture and Characterization of PSC

PSC that were isolated by density gradient centrifugation from rat pancreas showed the fat-storing phenotype with numerous fat droplets located in the perinuclear region of the cells (Figure 2A) . Within 4 to 8 days in primary culture, the number and the size of the fat droplets decreased, and the cells developed long cytoplasmic extensions (Figure 2B) and became weakly positive for {alpha}-smooth muscle actin. After passage the fat droplets almost completely disappeared and >90% of the cells expressed {alpha}-smooth muscle actin (Figure 2C) . The morphology of the passaged cells was stellate-like with long cytoplasmic extensions or spindle-shaped. Human PSC, which were obtained by outgrowth from small tissue blocks of fibrotic pancreas, were mostly stellate-like (a few were also spindle-shaped) without fat droplets in their cytoplasm. Already in primary culture these cells expressed {alpha}-smooth muscle actin and vimentin (data not shown).



View larger version (112K):
[in this window]
[in a new window]
 
Figure 2. Cultured pancreatic stellate cells. A: Oil red O staining of a primary cultured rat pancreatic stellate cell. PSC were isolated by density gradient centrifugation from the pancreas of untreated male Wistar rats and seeded in a density of 4 x 104 cells/cm2 on glass coverslips. Eighteen hours after seeding, cells were stained using oil red O and light microscopy was performed. The cell shows a triangular shape and numerous red-stained fat droplets (original magnification, x400). B: Phase contrast microscopy of primary cultured rat PSC. PSC were isolated and cultured as described in A. Forty-eight hours after seeding, phase contrast micoscopy was performed. Most cells are spindle-shaped and contain 6 to 20 perinuclear fat droplets (original magnification, x200). C: Fluorescence micrograph of secondary cultured human PSC. PSC were obtained by outgrowth from small tissue blocks of fibrotic pancreas. After reaching confluency, cells were passaged and seeded on glass coverslips. Three days later, cells were fixed with acetone and indirect immunofluorescence staining was performed using anti-iso-{alpha}-sm-actin (original magnification, x200).

 
Effect of Macrophage-Conditioned Media on Matrix Synthesis of Pancreatic Stellate Cells

To demonstrate paracrine stimulation of pancreatic stellate cell proliferation and matrix synthesis by soluble mediators produced by macrophages, macrophage-conditioned media were added to cultured human and rat PSC. The media had been conditioned for 24 hours by unstimulated and LPS-stimulated macrophages in the absence of FCS. Immunofluorescence staining of cell-associated collagen types I and III and fibronectin, Northern blot analyses of collagen type I and fibronectin, and quantitative immunoassay for collagen type I and c-fibronectin in cell culture supernatants were used to examine the effects of macrophage supernatants on ECM synthesis of PSC. The results obtained by the different methods were corresponding. In particular, transiently acidified media from LPS-activated macrophages significantly up-regulated ECM synthesis of cultured PSC.

To demonstrate the effects of macrophage supernatants on cell-associated collagens and fibronectin, secondary cultured human PSC grown on glass coverslips were incubated with 40 µl transiently acidified macrophage supernatant per milliliter of medium for 38 hours. Thereafter, cultures were fixed and immunostaining was performed. As shown in Figure 3 , intensive staining patterns of collagen type I (Figure 3C) , collagen type III (Figure 3F) , and fibronectin (Figure 3I) were observed in cultures receiving supernatants of LPS-activated macrophages. Collagens were detected predominantly intracellularly. Fibronectin was located predominantly extracellularly as fibrils, varying in staining intensity and in density. There was no significant difference in staining patterns between untreated cells (Figure 3, A, D, and G) and PSC incubated with conditioned media of unstimulated macrophages (Figure 3, B, E, and H) .



View larger version (106K):
[in this window]
[in a new window]
 
Figure 3. Fluorescence micrographs showing the immunoreactivity of collagen types I and III and fibronectin in cultured human PSC stimulated with macrophage supernatants. Secondary cultured human PSC grown on glass coverslips were stimulated for 38 hours with 40 µl transiently acidified macrophage supernatant per ml medium (DMEM/Ham’s F12 with 0.1% FCS). Thereafter cultures were washed, fixed in acetone and immunostaining was performed. A-C: collagen type I; D-F: collagen type III; G-I: fibronectin. A, D, G: control (without macrophage supernatant); B, E, H: PSC stimulated with supernatant of macrophages; C, F, I: PSC stimulated with supernatant of LPS-activated macrophages. Intensive staining patterns were observed in cultures receiving supernatants of LPS activated macrophages. Collagens were detected predominantly intracellularly. Fibronectin was located predominantly extracellularly as fibrils, varying in staining intensity and in density. There was no significant difference in staining patterns between untreated cells (A, D, G) and PSC incubated with conditioned media of unstimulated macrophages (B, E, H). Original magnification, x400.

 
To demonstrate the effects of macrophage supernatants on the steady state levels of collagen type I mRNA and fibronectin mRNA, secondary cultured human PSC were grown in 75-cm2 flasks containing 10 ml medium. To subconfluent quiescent cells grown for 12 hours without FCS, 400 µl of 10-fold concentrated transiently acidified macrophage supernatant was added in the presence of 0.1% FCS. Ten hours later cultures were stopped and mRNA was isolated. Unstimulated human PSC were used as a control. As shown in Figure 4 , unstimulated macrophage supernatant and, to a higher extent, supernatant from LPS-activated macrophages increased the steady state levels of collagen type I-mRNA and fibronectin-mRNA. The increase in collagen type I-mRNA is more pronounced than the increase of fibronectin mRNA.



View larger version (72K):
[in this window]
[in a new window]
 
Figure 4. Northern blot hybridization of collagen {alpha}1(I), fibronectin, and the 18S ribosomal RNA. Transiently acidified macrophage supernatants were added to secondary cultured human PSC. Ten hours later, cultures were stopped and RNA was isolated. RNA (30 µg/lane) was separated by agarose gel electrophoresis and transferred to Hybond-N membranes. Ethidium bromide staining of the agarose gels was used to verify equal loading and blotting of total RNA. Hybridizations were performed by standard procedures using 0.5 x 106 cpm/ml labeled cDNA. Exposure to X-ray films was done at -70°C for 7 to 10 days. Lane 1: RNA isolated from unstimulated PSC (control); Lane 2: RNA isolated from PSC stimulated with supernatant of macrophages; Lane 3: RNA isolated from PSC stimulated with supernatant of LPS-activated macrophages.

 
To demonstrate the effects of macrophage supernatants on c-fibronectin synthesis and secretion, c-fibronectin concentration was additionally measured by immunoassay in human and rat PSC supernatants. Collagen type I concentration was measured in human PSC supernatants only. Native and transiently acidified macrophage supernatants (40 and 160 µl/ml medium) were added to quiescent PSC; FCS had been reduced from 10% to 0.1% 12 hours before. The cultures were stopped 24 hours later. Collagen type I- and c-fibronectin synthesis is expressed on the basis of DNA. Native and, even more pronounced, transiently acidified supernatants of LPS-activated macrophages significantly accelerated fibronectin synthesis compared to unstimulated PSC (Figure 5) . Supernatants of unstimulated macrophages increased fibronectin synthesis only in rat PSC (Figure 5B) . The fibronectin synthesis-stimulating activity of macrophage supernatants was less pronounced in the presence of 0.5% FCS compared to 0.1% FCS (1.76 ± 0.07-fold vs. 2.80 ± 0.05-fold of control).



View larger version (39K):
[in this window]
[in a new window]
 
Figure 5. Effect of macrophage supernatants on fibronectin synthesis of cultured pancreatic stellate cells. Native and acidified macrophage supernatants (40 and 160 µl/ml medium) were added to secondary cultured PSC (A, human PSC; B, rat PSC). After 24 hours, cultures were stopped and fibronectin was measured in PSC supernatants; DNA was measured in the cell layer. Values are expressed as means ± SD of three independent experiments, each condition performed in triplicate culture wells. *P < 0.05.

 
To measure collagen type I concentration in supernatants of cultured PSC, ascorbic acid (100 µg/ml) and ß-aminopropionitrile (100 µg/ml) were added during the experiments to prevent collagen cross-linking and to increase proline hydroxylation. As shown in Figure 6 , transiently acidified supernatants of LPS-activated macrophages significantly increased collagen type I synthesis compared to the control cells. No significant stimulation of collagen type I synthesis was observed using native supernatant.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 6. Effect of macrophage supernatants on the synthesis of collagen type I in cultured human pancreatic stellate cells. Native and acidified macrophage supernatants (40 and 160 µl/ml medium) were added to pancreatic stellate cells cultured in DMEM/Hams F12 in the presence of 0.1% FCS, ascorbic acid (100 µg/ml) and ß-aminopropionitrile (100 µg/ml). After 24 hours cultures were stopped and collagen type I was measured in PSC supernatants; DNA was measured in the cell layer. Values are expressed as means ± SD of three independent experiments, each condition performed in triplicate culture wells. *P < 0.05.

 
TGFß1 Concentration in Macrophage Supernatants

To demonstrate that TGFß1 represents the fibrogenic mediator produced by activated macrophages, TGFß1 concentration was measured in supernatants of unstimulated and LPS stimulated macrophages by time-resolved fluorescence immunoassay. As expected, LPS activated macrophages produced 3.4-fold more TGFß (6.61 pg/µg DNA) compared to unstimulated macrophages (1.97 pg/µg DNA) in 24 hours.

Effect of Macrophage Supernatants on PSC Proliferation

To investigate the effect of macrophage supernatants on proliferation of cultured PSC, BrdU incorporation was measured during a labeling period of 18 hours. In preceding experiments optimal BrdU concentration and labeling time had been determined. Incorporated BrdU was quantitated using time-resolved fluorescence immunoassay. To determine an inhibitory effect of macrophage supernatants on PSC, proliferation cells were cultured in the presence of 10% FCS and to determine a stimulatory effect PSC were cultured in the presence of 0.1% FCS. Neither native nor acidified supernatants of unstimulated and LPS-stimulated macrophages showed any inhibitory or stimulatory effect on PSC proliferation.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
This is the first report demonstrating paracrine stimulation of pancreatic stellate cells via soluble mediators produced by mononuclear cells, in particular activated macrophages. The major findings in this study are: supernatants of cultured mononuclear cells stimulate the synthesis and secretion of collagen type I and c-fibronectin in cultured human and rat PSC; transient acidification of these supernatants (whereby TGFß is activated) accelerated the matrix synthesis-stimulating effect; and addition of LPS to cultured mononuclear cells increased TGFß1 synthesis and resulted in a higher ECM-stimulating activity of the supernatants. The enhanced stimulating activity after LPS treatment clearly points to the pivotal role of the macrophage population for TGFß production.

Chronic pancreatitis is histologically characterized by infiltration of leukocytes, duct alterations, and extended fibrosis.4 Leukocytes release cytokines and growth factors, eg, interleukin-1 (IL-1), IL-6, tumor necrosis factor {alpha} (TNF-{alpha}), and TGFß, which are suggested to induce proliferation of mesenchymal cells and accelerated deposition of the ECM.20,23,30-32 Emmerich at al13 described a three- to fourfold increased number of infiltrating macrophages in chronic pancreatitis and in pancreas carcinoma. The paracrine role of macrophages during wound repair in vivo has been demonstrated in studies that show that fibrosis is suppressed if monocyte infiltration is blocked.20 Activated macrophages release a number of cytokines including TGFß,20 which is suggested to represent one of the most prominent fibrogenic mediators.33 In liver TGFß stimulates hepatic stellate cell transformation30 and the synthesis of collagens,31 proteoglycans,32 and fibronectin.30 In early stages of pancreas fibrosis high numbers of mononuclear cells staining positively for both pro-TGFß and latent TGFß-binding protein (LTBP) were demonstrated.27 TGFß is secreted by almost all cell types in a latent, biologically inactive complex. One particular function of LTBP is to target the latent TGFß complex to the cell surface where activation occurs.34

Our data confirm earlier reports that activated (ie, LPS-treated) macrophages secrete TGFß.20 Macrophages activated by LPS secrete TGFß threefold compared to unstimulated cells. Interestingly, the TGFß1 mRNA steady state concentrations investigated by semiquantitative RT-PCR (data not shown) were similar in unstimulated compared to LPS-stimulated macrophages. These data are consistent with earlier reports on the regulation of TGFß gene expression and secretion of TGFß.20

Recently, we have shown on protein and mRNA level that serum stimulated the synthesis of collagen types I and III and fibronectin in cultured hPSC.11 It has been suggested that aggregating platelets release the matrix synthesis-stimulating mediators. However, now we present data demonstrating that macrophage supernatants, in particular supernatants from LPS-activated macrophages, increased the steady-state mRNA levels of fibronectin and collagen type I in cultured hPSC. Furthermore, prominent staining patterns of collagen types I and III and fibronectin were found intracellularly and extracellularly in hPSC after stimulation with conditioned medium from LPS-activated macrophages. Transient acidification of the macrophage supernatants (before addition to cultured PSC) increased collagen type I and fibronectin concentration in PSC supernatants compared to native supernatants (see Figures 5 and 6 ). This observation indicates that TGFß might represent the responsible fibrogenic mediator in macrophage supernatants. In experiments with PSC cultured in the presence of 0.5% FCS (instead of 0.1% FCS) the stimulatory effect of the macrophage supernatants on fibronectin synthesis was still significant but less pronounced (1.7-fold versus threefold). This result is in line with previous data demonstrating that among several polypeptide growth factors present in serum (bFGF, PDGF, insulin-like growth factors, TGBß, TNF{alpha}, TGF{alpha}) only TGFß1 was able to stimulate fibronectin synthesis in the presence of higher serum concentrations.11 The importance of TGFß in experimental and human pancreas fibrogenesis is documented by several studies.33 In rat cerulein pancreatitis TGFß1 gene expression parallels collagen type I gene expression.10 Interestingly, TGFß1 protein increased earlier than TGFß mRNA in pancreas tissue, suggesting that platelets might be the source of the early TGFß1 protein increase.10 Thereafter TGFß1 is released by inflammatory cells, stromal cells, and acinar cells.10 To inhibit the TGFß effects during regeneration from cerulein pancreatitis in rats, Menke et al35 injected TGFß1-neutralizing antibodies and could show by this approach that collagen types I and III protein and mRNA deceased significantly compared to control (without anti-TGFß1). Furthermore, anti-TGFß1 inhibited the usually observed rise of the steady state levels of TGFß1 mRNA and TGFß2 mRNA at the second day after cerulein infusion,35 suggesting that the early TGFß1 release by platelets induces the TGFß synthesis. In summary, the data obtained in experimental models convincingly identified TGFß as the most prominent fibrogenic mediator in pancreas.

In addition to the paracrine stimulation of ECM synthesis (eg, via TGFß), macrophages modulate matrix turnover by producing the 92-kd gelatinase matrix metalloproteinase-9 and the interstitial collagenase matrix metalloproteinase-1.36-38 Because TGFß reduces matrix metalloproteinase synthesis,39 net matrix accumulation is accelerated by an increased synthesis and a decreased matrix degradation.

In conclusion, our data indicate that activated macrophages might cooperate with pancreatic stellate cells in the development of pancreas fibrosis by secreting fibrogenic mediators (in particular TGFß), thus stimulating ECM synthesis in a paracrine way. Future studies will analyze the role of metalloproteinases in cell-cell interactions of PSC and inflammatory cells.


    Acknowledgements
 
We thank Martina de Groot, Martina Adam-Jäger, and Erika Schmidt for expert technical assistance.


    Footnotes
 
Address reprint requests to Dr. A. Schmid-Kotsas, Universität Ulm - Klinikum, Institut für Klinische Chemie, MB, Prittwitzstrasse 43, D-89070 Ulm, Germany. E-mail: alexandra.schmid-kotsas{at}medizin.uni-ulm.de

Supported by Bausteinförderung University of Ulm (P.347) and Deutsche Forschungsgemeinschaft (SFB 518, Project A7) to M. G. B.

Accepted for publication July 15, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Sarles H, Bernard JP, Johnson C: Pathogenesis and epidemiology of chronic pancreatitis. Ann Rev Med 1989, 40:453-468[Medline]
  2. Tsukamoto H, Towner SJ, Yu GSM, French SW: Potentiation of ethanol-induced pancreatic injury by dietary fat. Am J Pathol 1988, 131:246-257[Abstract]
  3. Morohoshi T, Kanda M: Periacinar fibroblastoid cell: its action on early stage of alcoholic pancreatitis. J Biliary Tract Pancreas 1985, 6:1205-1211(in Japanese)
  4. Di Magno EP, Layer P, Clain JE: Chronic pancreatitis. 21st ed. Go VWL Di Magno EP Gardner JD eds. The Pancreas, 1993, :pp 655-706 Raven Press, New York
  5. Elsässer HP, Adler G, Kern HF: Fibroblast structure and function during regeneration from hormone-induced acute pancreatitis in the rat. Pancreas 1989, 4:169-178[Medline]
  6. Elsässer HP, Haake T, Grimmig M, Adler G, Kern HF: Repetitive cerulein-induced pancreatitis and pancreatic fibrosis in the rat. Pancreas 1992, 7:385-390[Medline]
  7. Kato Y, Inoue H, Fujiyama Y, Bamba T: Morphological identification and collagen synthesis of periacinar fibroblastoid cells isolated and cultured from rat pancreatic acini. J Gastroenterol 1996, 31:565-571[Medline]
  8. Saotome T, Inoue H, Fujimiya M, Fujiyama Y, Bamba T: Morphological and immunocytochemical identification of periacinar fibroblast-like cells derived from human pancreatic acini. Pancreas 1997, 14:373-382[Medline]
  9. Elsässer HP, Adler G, Kern HF: Time course and cellular source of pancreatic regeneration following acute pancreatitis. Pancreas 1986, 5:421-429
  10. Gress M, Müller-Pillasch F, Elsässer HP, Bachem M, Ferrara C, Weidenbach H, Lerch M, Adler G: Enhancement of transforming growth factor 1 expression in the rat pancreas during regeneration from caerulein-induced pancreatitis. Eur J Clin Invest 1994, 24:679-685[Medline]
  11. Bachem MG, Schneider E, Gross H, Widenbach H, Schmid RM, Menke A, Siech M, Beger H, Grünert A, Adler G: Identification, culture, and characerization of pancreatic stellate cells in rats, and humans. Gastroenterology 1998, 115:421-432[Medline]
  12. Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, Pirola RC, Wilson JS: Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998, 43:128-133[Abstract/Free Full Text]
  13. Emmerich J, Weber I, Nausch M, Sparmann G, Koch K, Seyfarth M, Löhr M, Liebe S: Immunohistochemical characterization of the pancreatic cellular infiltrate in normal pancreas, chronic pancreatitis and pancreatic carcinoma. Digestion 1998, 59:192-198[Medline]
  14. Wahl SM, McCartney-Francis N, Mergenhagen SE: Inflammatory and immunoregulatory roles of TGFß. Immunol Today 1989, 10:258-261[Medline]
  15. Rabinovitch A, Suarez-Pinzon WL: Cytokines and their role in pancreatic islet ß-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998, 55:1139-1149[Medline]
  16. Gianotti L, Munda R, Alexander JW, Tchervenkov JI, Babcock GF: Bacterial translocation: a potent source for infection in acute pancreatitis. Pancreas 1993, 8:551-558[Medline]
  17. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS), and LPS binding protein. Science 1990, 249:1431-1433[Abstract/Free Full Text]
  18. Ferrero E, Jian D, Tsuberi BZ, Tesio L, Rong GW, Haziot A, Goyert SM: Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 1993, 90:2380-2384[Abstract/Free Full Text]
  19. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB: Transforming growth factor-ß in human platelets: identification of a major storage site, purification and characterization. J Biol Chem 1983, 258:7155-7160[Abstract/Free Full Text]
  20. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Maotes DK, Raines EW, Ross R, Sporn MB: Expression and secretion of type ß transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987, 84:6020-6024[Abstract/Free Full Text]
  21. De Bont N, Netea HG, Rovers C, Smilde T, Demacker PNM, van der Meer JWM, Stalenhoef AFH: LPS-induced cytokine production and expression of LPS-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors. Atherosclerosis 1998, 139:147-152[Medline]
  22. Bockmann DE, Büchler M, Beger HG: Ultrastructure of human acute pancreatitis. Int J Pancreatol 1986, 1:141-153[Medline]
  23. Lyons RM, Moses HL: Transforming growth factors and the regulation of cell proliferation. Eur J Biochem 1990, 187:467-473[Medline]
  24. Sporn MB, Roberts AB: Transforming growth factor ß: recent progress and new challenges. J Cell Biol 1992, 119:1017-1021[Free Full Text]
  25. Kanzaki T, Oloffson A, Moren A, Wernstedt C, Hellman U, Miyazono K, Claesson-Welsh L, Heldin CH: TGFß1-binding protein: a component of the large complex of TGFß1 with multiple repeat sequences. Cell 1990, 61:1051-1061[Medline]
  26. Miyazono K, Olofsson A, Colosetti P, Heldin CH: A role of the latent TGFß1-binding protein in the assembly and secretion of TGFß1. EMBO J 1991, 10:1091-1101[Medline]
  27. Van Laethem JL, Deviere J, Resibois A, Rickaert F, Vertongen P, Ohtani H, Cremer M, Miyazono K, Robberecht P: Localization of transforming growth factor ß1 and its latent binding protein in human chronic pancreatitis. Gastroenterology 1995, 108:1873-1881[Medline]
  28. Labarca C, Paigen K: A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980, 102:344-352[Medline]
  29. Bachem MG, Dietz R, Gressner AM: Quantitative measurement of cell proliferation using incorporation of 5-bromo-2-deoxyuridine, monoclonal antibody against 5-bromo-2-deoxyuridine (Mab anti-BrdUrd) and time-resolved fluorometry of europium chelat. Eur J Clin Chem Clin Biochem 1995, 33:A30(abstract)
  30. Bachem MG, Sell KM, Melchior R, Kropf J, Eller T, Gressner AM: Tumor necrosis factor a and transforming growth factor ß1 stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells into myofibroblasts. Virchows Arch Cell Pathol 1993, 63:123-130
  31. Matsuoka M, Tsukamoto H: Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming factor ß: implication of a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 1990, 11:599-605[Medline]
  32. Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM: Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. J Clin Invest 1992, 89:19-27
  33. Gress TM, Menke A, Bachem M, Müller-Pillasch F, Ellenrieder V, Weidenbach H, Wagner M, Adler G: Role of extracellular matrix in pancreatic diseases. Digestion 1998, 59:625-637[Medline]
  34. Flaumenhaft R, Abe M, Sato Y, Miyazono K, Harpel J, Heldin CH, Rifkin DB: Role of the latent TGF-ß binding protein in the activation of latent TGF by co-culture of endothelial and smooth muscle cells. J Cell Biol 1993, 120:995-1002[Abstract/Free Full Text]
  35. Menke A, Yamaguchi H, Gress TM, Adler G: Extracellular matrix is reduced by inhibition of transforming growth factor ß1 in pancreatitis in the rat. Gastroenterology 1997, 113:295-303[Medline]
  36. Zhang Y, McClusky K, Fujii K, Wahl LM: Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-{alpha}, granulocyte-macrophage CSF, and IL-1 ß through prostaglandin-dependent and -independent mechanisms. J Immunol 1998, 161:3071-3076[Abstract/Free Full Text]
  37. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM: IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 1995, 96:2304-2310
  38. Pierce RA, Sandefur S, Doyle GA, Welgus HG: Monocytic cell type-specific transcriptional induction of collagenase. J Clin Invest 1996, 97:1890-1899[Medline]
  39. Edwards DR, Murphy G, Reynolds JJ: Transforming growth factor ß modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987, 6:1899-1904[Medline]



This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
B. Reinhardt, M. Winkler, P. Schaarschmidt, R. Pretsch, S. Zhou, B. Vaida, A. Schmid-Kotsas, D. Michel, P. Walther, M. Bachem, et al.
Human cytomegalovirus-induced reduction of extracellular matrix proteins in vascular smooth muscle cell cultures: a pathomechanism in vasculopathies?
J. Gen. Virol., October 1, 2006; 87(Pt 10): 2849 - 2858.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. Sparmann, A. Glass, P. Brock, R. Jaster, D. Koczan, H.-J. Thiesen, S. Liebe, and J. Emmrich
Inhibition of lymphocyte apoptosis by pancreatic stellate cells: impact of interleukin-15
Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G842 - G851.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. J. van Westerloo, S. Florquin, A. M. de Boer, J. Daalhuisen, A. F. de Vos, M. J. Bruno, and T. van der Poll
Therapeutic Effects of Troglitazone in Experimental Chronic Pancreatitis in Mice
Am. J. Pathol., March 1, 2005; 166(3): 721 - 728.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. Sparmann, C. Hohenadl, J. Tornoe, R. Jaster, B. Fitzner, D. Koczan, H.-J. Thiesen, A. Glass, D. Winder, S. Liebe, et al.
Generation and characterization of immortalized rat pancreatic stellate cells
Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G211 - G219.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A Zimmermann, B Gloor, A Kappeler, W Uhl, H Friess, and M W Buchler
Pancreatic stellate cells contribute to regeneration early after acute necrotising pancreatitis in humans
Gut, October 1, 2002; 51(4): 574 - 578.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. Schneider, A. Schmid-Kotsas, J. Zhao, H. Weidenbach, R. M. Schmid, A. Menke, G. Adler, J. Waltenberger, A. Grunert, and M. G. Bachem
Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells
Am J Physiol Cell Physiol, August 1, 2001; 281(2): C532 - C543.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Yoshikawa, Y. Kihara, M. Taguchi, T. Yamaguchi, H. Nakamura, and M. Otsuki
Role of TGF-beta 1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima Fatty rats
Am J Physiol Gastrointest Liver Physiol, March 1, 2002; 282(3): G549 - G558.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmid-Kotsas, A.
Right arrow Articles by Bachem, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmid-Kotsas, A.
Right arrow Articles by Bachem, M. G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS